1 – 10 of 232
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
- Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism
-
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage
Cicognola, Claudia LU
;
Satir, Tugce Munise
;
Brinkmalm, Gunnar
;
Matečko-Burmann, Irena
;
Agholme, Lotta
;
Bergström, Petra
;
Becker, Bruno
;
Zetterberg, Henrik
LU
;
Blennow, Kaj
LU
and
Höglund, Kina
(2020)
In Journal of Alzheimer's disease : JAD
Mark
-
Biomarker profiling beyond amyloid and tau : cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
Idland, Ane Victoria ; Sala-Llonch, Roser ; Watne, Leiv Otto ; Brækhus, Anne ; Hansson, Oskar LU
;
Blennow, Kaj
LU
;
Zetterberg, Henrik
LU
;
Sørensen, Øystein
;
Walhovd, Kristine Beate
and
Wyller, Torgeir Bruun
, et al.
(2020)
In Neurobiology of Aging
93.
p.1-15
Mark
- Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration : A translatable marker of synaptic degeneration
- Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
-
Plasma P-tau181 in Alzheimer’s disease : relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
Janelidze, Shorena LU ; Mattsson, Niklas LU ; Palmqvist, Sebastian LU
;
Smith, Ruben
LU
;
Beach, Thomas G.
;
Serrano, Geidy E.
;
Chai, Xiyun
;
Proctor, Nicholas K.
;
Eichenlaub, Udo
and
Zetterberg, Henrik
LU
, et al.
(2020)
In Nature Medicine
26(3).
p.379-386
Mark
-
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Llorens, Franc ; Hermann, Peter ; Villar-Piqué, Anna ; Diaz-Lucena, Daniela ; Nägga, Katarina LU ; Hansson, Oskar LU
;
Santana, Isabel
;
Schmitz, Matthias
;
Schmidt, Christian
and
Varges, Daniela
, et al.
(2020)
In Nature Communications
11.
Mark
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders